Loading...
Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment
Context: Adjuvant chemotherapy is associated with significant reductions in bone mineral density (BMD) in premenopausal women with breast cancer (BC) that is prevented with zoledronic acid (ZA) every 3 months for 1 yr. Objective: The aim of the study was to examine the effect on BMD of discontinuing...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Endocrine Society
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2840866/ https://ncbi.nlm.nih.gov/pubmed/20022990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2009-1366 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|